FORM 10-K

Company

IGC Pharma, Inc.

Filed

June 27, 2025

Period of Report

March 31, 2025

Accession Number

0001185185-25-000706

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →